AzTrials
AzTrials

HypotensionPhase 4NCT02802683

Hemodynamic Impact of Hyperbaric Versus Isobaric for Spinal Anesthesia During Cesarean Delivery

A Phase 4 study testing Bupivacaine, Levobupivacaine and Phenylephrine in people with Hypotension, run by Seoul National University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the frequency of hypotension between hyperbaric anesthetics and isobaric anesthetics during cesarean section and determine whether continuous infusion of phenylephrine is effective in mothers who received hyperbaric anesthetics. Read more about this study

Who is it for?
Ages 19 to 45 years, women only
Conditions the study is for
Hypotension
What is being tested?
Bupivacaine, Levobupivacaine and Phenylephrine
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
72 participants
Where
1 siteSouth Korea
Study dates
Sep 2015to Jun 2016
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • pregnant woman scheduled for elective cesarean delivery under spinal anesthesia

Who cannot join

  • patients who refuse involved
  • patients who have pre-eclampsia
  • patients who have heart disease
  • patients who fetal distress is suspicious

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Hospital

    Seoul, Seoul, 110-744

Other trials in South Korea

About this study

The purpose of this study is to compare the frequency of hypotension between hyperbaric anesthetics and isobaric anesthetics during cesarean section and determine whether continuous infusion of phenylephrine is effective in mothers who received hyperbaric anesthetics.

Conditions
Hypotension
Being tested
Bupivacaine, Levobupivacaine, Phenylephrine, normal saline
Keywords
Hypotension, cesarean section
Medical subject headings
Hypotension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BupivacaineDrug

    Also called Heavy bupivacaine

    spinal anesthesia with hyperbaric bupivacaine

  • LevobupivacaineDrug

    Also called chirocaine

    spinal anesthesia with isobaric levobupivacaine

  • PhenylephrineDrug

    continous infusion of phenylephrine

  • normal salineDrug

    continous infusion of normal saline

Study groups in NCT02802683
Study groupRoleWhat they receive
"BUPI","P"Experimentalpatients who received hyperbaric bupivacaine and continous infusion of phenylephrine
Receives: Drug: Bupivacaine; Drug: Phenylephrine
"BUPI","N"Placebo comparatorpatients who received hyperbaric bupivacaine and continous infusion of normal saline
Receives: Drug: Bupivacaine; Drug: normal saline
"LEVO","P"Experimentalpatients who received isobaric levobupivacaine and continous infusion of phenylephrine
Receives: Drug: Levobupivacaine; Drug: Phenylephrine
"LEVO","N"Active comparatorpatients who received isobaric levobupivacaine and continous infusion of normal saline
Receives: Drug: Levobupivacaine; Drug: normal saline

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of hypotension events with treatment related

    blood pressure was obtained every 1min. A 20% decrease or more decrease in SAP compared to baseline was considered as hypotension. Hypotensive events during first 30 min was recorded as primary outcome.

    Measured: during 30min after spinal anesthesia

Secondary outcomes (1)
  1. total dose of phenylephrine

    Measured: during the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2016 (estimated)
  2. Study startSep 2015
  3. Primary completionMay 2016
  4. Study completionJun 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02802683
Sponsor's protocol ID
JHBahk_C/S
Status last verified
Jul 2016
First submitted
4 May 2016
Last updated
6 Jul 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Bupivacaine, Levobupivacaine and Phenylephrine in people with Hypotension, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of hypotension events with treatment related (time frame: during 30min after spinal anesthesia). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in